Actively Recruiting
Clinical Comparison of Drug-Coated Balloon and Drug-Eluting Stent Interventions in Multivessel Coronary Artery Disease Patients A Randomized, Multicenter, Single-Blind Trial
Led by Genoss Co., Ltd. · Updated on 2026-10-09
892
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing two types of percutaneous coronary interventions PCI for patients with multivessel coronary artery disease affecting vessels 2.25 mm to 4.0 mm in diameter. This randomized, single-blind, multicenter trial aims to evaluate the clinical outcomes of drug-coated balloon-based PCI versus drug-eluting stent-based PCI. Approximately nine hospitals will participate to assess which treatment approach may better address coronary artery lesions in this patient group. Participants are randomly assigned to receive either a paclitaxel-coated PTCA balloon catheter GENOSS DCB or a contemporary drug-eluting stent DES with biodegradable or durable polymer coatings. Lesion preparation for DCB treatment is performed after randomization based on the treatment strategy. The study compares the treatments over time, focusing initially on a 12-month period for the primary outcome and extending to 36 months for secondary outcomes. During the study, participants will be monitored for the time to the first occurrence of a net clinical outcome NCO within 12 months after randomization. Further assessments include cardiovascular events, bleeding, deaths, myocardial infarction, revascularization, stent thrombosis, and stroke up to 36 months post-procedure. Participants will undergo evaluations according to the study schedule, which involves regular monitoring to track these outcomes and ensure safety throughout the study period.
CONDITIONS
Brief Title
Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD
Research Team
E
Eun-Seok Shin, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here